Cosmeceuticals for children: should you care?

Anh Khoa Pham1, James G Dinulos

  • 1aGeisel School of Medicine at Dartmouth, Hanover, New Hampshire bUniversity of Connecticut, Farmington, Connecticut, USA.

Insights

Cosmeceuticals are popular antiaging skin products, but studies on their use in children are limited. Pediatricians should be aware of potential side effects like skin irritation from these increasingly common products.

Area of Science:

  • Dermatology
  • Pediatric Dermatology
  • Cosmeceutical Science

Background:

  • Cosmeceuticals are widely used for antiaging, offering alternatives to invasive procedures.
  • Limited research exists on cosmeceutical safety and efficacy in pediatric populations.
  • The US Food and Drug Administration does not recognize cosmeceuticals as a distinct category, lacking specific regulatory oversight.

Purpose of the Study:

  • To review the current understanding of cosmeceutical use in children.
  • To highlight the lack of pediatric-specific safety and efficacy data for cosmeceuticals.
  • To inform healthcare providers about the growing use of cosmeceuticals by adolescents for preventive antiaging.

Main Methods:

  • Literature review of studies on cosmeceutical mechanisms and applications.
  • Analysis of existing research focusing on skin aging and cosmeceutical ingredients.
  • Examination of cosmeceutical product types commonly accessible to children and adolescents.

Main Results:

  • Scientific basis for cosmeceuticals involves understanding skin aging mechanisms (e.g., oxidative stress, hormonal changes, UV radiation).
  • Commonly used cosmeceuticals include retinoids, botanicals, moisturizers, and sunscreens.
  • Moisturizers and sunscreens are most prevalent among younger children, while teenagers may use a wider range for prevention.

Conclusions:

  • Pediatricians need to be informed about cosmeceuticals, particularly broad-spectrum sunscreens.
  • Increased exposure to cosmeceuticals in children may lead to adverse effects like contact dermatitis and irritation.
  • Further research is essential to establish safety and efficacy profiles for pediatric cosmeceutical use.
Abstract

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.4K
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.4K
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
91
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
955
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K